Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2018 May;84(5) > Minerva Anestesiologica 2018 May;84(5):546-55

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

ORIGINAL ARTICLE   Free accessfree

Minerva Anestesiologica 2018 May;84(5):546-55

DOI: 10.23736/S0375-9393.17.12065-1

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

The analgesic potency dose of remifentanil to minimize stress response induced by intubation and measurement uncertainty of Surgical Pleth Index

Ji H. PARK 1, Dong-Hee KIM 2, Sun-Kook YOO 3, Hyun-Jun LIM 4, Joo-Won LEE 5, Won-S. AHN 6, Eun-Kyung LEE 7, Byung-M. CHOI 5 , Gyu-Jeong NOH 5, 8

1 Department of Anesthesiology and Pain Medicine, Hangang Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea; 2 University of Ulsan College of Medicine, Seoul, South Korea; 3 Department of Medical Engineering, Yonsei University College of Medicine, Seoul, South Korea; 4 Graduate School of Biomedical Engineering, Yonsei University, Seoul, South Korea; 5 Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; 6 Blood Flow Data Center, Kyunghee University Medical Center, Seoul, South Korea; 7 Department of Statistics, Ewha Womans University, Seoul, South Korea; 8 Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea



BACKGROUND: The aim of this study was to evaluate the analgesic potency dose of remifentanil to maintain Surgical Pleth Index (SPI) values at less than 50 after intubation in patients undergoing general anesthesia with target-controlled infusion of propofol and remifentanil.
METHODS: We randomly allocated 120 patients to receive one of three remifentanil target effect-site concentrations (5, 7, or 9 ng×mL-1) during intubation. The target effect-site concentrations of propofol were adjusted within a range of 2.5-3 μg×mL-1 to maintain bispectral index values at less than 60 during anesthesia induction. A reusable SPI sensor was placed on the index finger of the arm, and the SPI values were continuously recorded. The predicted probability for maintaining the SPI values at less than 50 after intubation against the cumulative amount of remifentanil was analyzed using logistic regression. The measurands were the baseline SPI value in patients without pain scheduled for surgery, and the maximal SPI value after intubation in patients receiving remifentanil with a target effect-site concentration of 7 ng×mL-1.
RESULTS: The estimated cumulative amount of remifentanil associated with a 50% and 95% probability of maintaining the SPI values at less than 50 after intubation were 135.0 µg and 330.4 µg, respectively. The estimated expanded uncertainty for the baseline and maximal SPI values after intubation in patients scheduled for surgery were 54.9±44.4 and 54.1±37.9, respectively, which corresponded to a confidence level of approximately 95%.
CONCLUSIONS: The analgesic potency dose of remifentanil to maintain SPI values at less than 50 after intubation was 135.0 µg.


KEY WORDS: Intubation - Remifentanil - Stress, physiological - Surgery

top of page